5-16572044-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001034850.3(RETREG1):​c.379C>T​(p.Arg127Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00723 in 1,613,468 control chromosomes in the GnomAD database, including 56 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R127H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0057 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0074 ( 52 hom. )

Consequence

RETREG1
NM_001034850.3 missense

Scores

2
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.73

Publications

10 publications found
Variant links:
Genes affected
RETREG1 (HGNC:25964): (reticulophagy regulator 1) The protein encoded by this gene is a cis-Golgi transmembrane protein that may be necessary for the long-term survival of nociceptive and autonomic ganglion neurons. Mutations in this gene are a cause of hereditary sensory and autonomic neuropathy type IIB (HSAN IIB), and this gene may also play a role in susceptibility to vascular dementia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]
RETREG1 Gene-Disease associations (from GenCC):
  • neuropathy, hereditary sensory and autonomic, type 2B
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009130418).
BP6
Variant 5-16572044-G-A is Benign according to our data. Variant chr5-16572044-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 377837.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00572 (870/152102) while in subpopulation NFE AF = 0.00799 (543/67998). AF 95% confidence interval is 0.00743. There are 4 homozygotes in GnomAd4. There are 452 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RETREG1NM_001034850.3 linkc.379C>T p.Arg127Cys missense_variant Exon 2 of 9 ENST00000306320.10 NP_001030022.1 Q9H6L5-1
RETREG1XM_011514053.4 linkc.379C>T p.Arg127Cys missense_variant Exon 2 of 10 XP_011512355.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RETREG1ENST00000306320.10 linkc.379C>T p.Arg127Cys missense_variant Exon 2 of 9 1 NM_001034850.3 ENSP00000304642.9 Q9H6L5-1

Frequencies

GnomAD3 genomes
AF:
0.00572
AC:
870
AN:
151984
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00147
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00393
Gnomad ASJ
AF:
0.00260
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0180
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00798
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00642
AC:
1602
AN:
249488
AF XY:
0.00624
show subpopulations
Gnomad AFR exome
AF:
0.00103
Gnomad AMR exome
AF:
0.00281
Gnomad ASJ exome
AF:
0.00169
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0155
Gnomad NFE exome
AF:
0.00956
Gnomad OTH exome
AF:
0.00793
GnomAD4 exome
AF:
0.00739
AC:
10799
AN:
1461366
Hom.:
52
Cov.:
30
AF XY:
0.00709
AC XY:
5156
AN XY:
727034
show subpopulations
African (AFR)
AF:
0.000986
AC:
33
AN:
33474
American (AMR)
AF:
0.00266
AC:
119
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00134
AC:
35
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.000185
AC:
16
AN:
86256
European-Finnish (FIN)
AF:
0.0157
AC:
841
AN:
53412
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00842
AC:
9359
AN:
1111542
Other (OTH)
AF:
0.00654
AC:
395
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
525
1051
1576
2102
2627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
332
664
996
1328
1660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00572
AC:
870
AN:
152102
Hom.:
4
Cov.:
32
AF XY:
0.00608
AC XY:
452
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.00147
AC:
61
AN:
41482
American (AMR)
AF:
0.00392
AC:
60
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00260
AC:
9
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4806
European-Finnish (FIN)
AF:
0.0180
AC:
190
AN:
10562
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00799
AC:
543
AN:
67998
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
41
82
123
164
205
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00656
Hom.:
9
Bravo
AF:
0.00437
TwinsUK
AF:
0.00593
AC:
22
ALSPAC
AF:
0.00856
AC:
33
ESP6500AA
AF:
0.000806
AC:
3
ESP6500EA
AF:
0.00792
AC:
65
ExAC
AF:
0.00700
AC:
846
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00687
EpiControl
AF:
0.00557

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RETREG1: BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Neuropathy, hereditary sensory and autonomic, type 2B Benign:2
Jul 12, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

RETREG1-related disorder Benign:1
May 22, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not specified Benign:1
Oct 19, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Inborn genetic diseases Benign:1
Jul 22, 2020
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.45
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0051
T
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.18
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.77
T
MetaRNN
Benign
0.0091
T
MetaSVM
Benign
-1.1
T
PhyloP100
1.7
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
0.23
N
REVEL
Benign
0.079
Sift
Benign
0.16
T
Sift4G
Benign
0.21
T
Polyphen
0.027
B
Vest4
0.43
MVP
0.47
MPC
0.45
ClinPred
0.016
T
GERP RS
4.0
PromoterAI
-0.018
Neutral
Varity_R
0.058
gMVP
0.47
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78314670; hg19: chr5-16572153; API